Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clerz2
- Development stage
- Unknown
- Lead developer
- Alcon
- Modality
- Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Ophthalmic
01
Overview
Clerz2 is an over-the-counter ophthalmic solution marketed as a rewetting eye drop. It is used to relieve dryness and discomfort associated with contact lens wear. The product is designed to lubricate the eyes and help alleviate symptoms such as ocular itching and burning that can occur during contact lens use. There are no indications that it contains pharmaceutical active ingredients for disease treatment; rather, it functions as a comfort aid for contact lens users[9].
- Brand names
- Clerz2Clerz-2Clerz 2
- Other names
- Clerz 2Clerz2Clerz-2Clerz II
Beyond the preview
Go deeper on Clerz2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clerz2.